Hirotsugu Uemura
Sakai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 290 publications
Therapeutic effects of imidazoline 2 receptor activation on lower urinary tract dysfunction in a mouse model of spinal cord injury.
Journal: American journal of physiology. Renal physiology
Published: March 28, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE Study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: January 18, 2026
Circulating Tumor DNA Genomic Profiling in 223Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 11, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.
Journal: Prostate cancer and prostatic diseases
Published: January 03, 2026
Impact of radium-223 on bone imaging and biochemical markers with and without bone-modifying agents in bone-metastatic castration-resistant prostate cancer: results from the kyucog-1901 study.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 24, 2025
Efficacy of Cabozantinib in Patients With Advanced Renal Cell Carcinoma With Bone Metastasis Assessed by Modified MD Anderson Criteria: An Open-Label Phase 2 Study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: December 19, 2025
Two stress-responsive kinases suppress ferroptosis by activating antioxidant programs under mild oxidative stress.
Journal: Signal transduction and targeted therapy
Published: October 02, 2025
Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study.
Journal: The Prostate
Published: September 03, 2025
Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE Study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: July 29, 2025
Last Updated: 09/26/2026